David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), bought 1,500 shares at $4.11 ($6K) on 2017-11-16, disclosed to the SEC on 2017-11-17.
Open-market purchase of $6k TTOO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2019-06-13 | $5K | — | Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-06-08 | $35K | — | Filing → |